A systems and computational biology perspective on advancing CAR therapy

Area of Science:

• Immunology
• Computational Biology
• Oncology

Background:

• Chimeric antigen receptor (CAR) therapy represents a significant advancement in cancer treatment, engineering immune cells to target tumors.
• Despite FDA approvals and ongoing clinical trials, the precise mechanisms of CAR therapy are not fully understood.

Purpose of the Study:

• To provide a comprehensive review of systems and computational biology approaches applied to CAR therapy.
• To elucidate the operating principles of CAR therapy and guide future design improvements.

Main Methods:

• Discussion of various computational models of CAR therapy, spanning from organismal to molecular scales.
• Description of the molecular and functional characteristics of costimulatory domains used in CAR constructs.
• Explanation of the signaling pathways activated by costimulatory domains leading to cellular anti-tumor responses.

Main Results:

• Identification of diverse computational modeling strategies for CAR therapy analysis.
• Detailed characterization of key costimulatory domains and their roles in CAR function.
• Elucidation of signaling cascades essential for CAR-mediated immune responses against cancer cells.

Conclusions:

• Systems and computational biology are vital for advancing CAR therapy research and development.
• A comprehensive understanding of CAR mechanisms can accelerate the design of more effective cancer treatments.
• This review encourages further integration of systems approaches to optimize CAR therapy.